Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.8 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |